Blog
Convalescent plasma: How some recovered COVID-19 patients are paying back their good fortune
May 29, 2020
The concept is “convalescent plasma,” a time-honored healing art that has saved patients with diphtheria, measles and the Spanish flu going back to the late 19th century. Plasma is the colorless, liquid portion of the blood. In recovered COVID-19 patients, these plasma-based antibodies presumably provide a period of immunity and may also help recovery of actively infected patients.
Keep your research on track
May 18, 2020
Although the coronavirus pandemic has turned our worlds upside down, it’s important for you to land on your feet. We want to help. If you work in a medical research organization, you may have or slowed or paused projects because of social distancing, or you may have pivoted to accelerate work on coronavirus treatments, tests or vaccines.
Let’s stick to the mission
May 7, 2020
When research is on hold, so, in some cases, are patients’ hopes for relief. That’s why it’s important to remember that even if you, as a researcher, are separated from your work, you can continue valuable activities in the background, e.g., project design, planning and preparation.
Joining the fight against COVID-19
April 23, 2020
We all yearn to get back to our regular lives, whatever that may look like, as soon as possible. For the sick, that means reclaiming good health. For the sheltered in place, it means seeing our friends. For health care workers, first responders, grocery store employees and others who mix with the public, regular life means a sense of personal safety.
New saliva-based coronavirus testing approach wins FDA emergency use authorization
April 16, 2020
Testing for COVID-19 needs to be pervasive, but if you had a choice in methods, would you prefer a swab deep into your nasal cavity or the option to spit in a cup? The latter is now a potential alternative testing approach thanks to the work of Rutgers’ RUCDR Infinite Biologics and its collaborators, who just won FDA emergency use authorization for the collection method.
Here for you in every possible way during the COVID-19 outbreak
March 23, 2020
We hope you are safe and well and taking all necessary steps to stay that way. In a time like this, one marvels at how much effort has gone into medical progress over the centuries, as well as the importance of science now under way.
Scientists can guess your age from your microbes
March 12, 2020
Microorganisms on and in your body can tell scientists your age – sometimes within four years– setting the stage for new interventions and diagnostic tools built on analyses of microbes in your mouth, on your skin, and in your fecal matter.
Experimental liquid biopsy predicts gastric cancer recurrence
March 5, 2020
A blood draw has successfully predicted the recurrence of gastric cancer long before it would otherwise be detectible in the latest example of liquid biopsy’s promise.
We make it easier to access a deeper supply of hematologic tissue, multipotent stem and immune cells
February 20, 2020
Life science researchers are increasingly discovering the value that iSpecimen’s Marketplace and its growing network of supply partners – hospitals, clinical labs, biobanks, blood collection centers, and healthy cell processing sites – provide by enabling increased access to large cohorts of specimens and annotated data, efficiently and in a scalable way.
Researchers flip drug discovery script, unleashing thousands of medicines on cancer cells
February 13, 2020
Instead of starting with a disease and looking for a cure, Boston area researchers recently started with thousands of drugs and watched what they did to cancer.
Previous |
- © 2020 iSpecimen, Inc.
- All rights reserved.
